...
首页> 外文期刊>The Annals of applied statistics >Hierarchical Bayesian analysis of somatic mutation data in cancer
【24h】

Hierarchical Bayesian analysis of somatic mutation data in cancer

机译:癌症中体细胞突变数据的分层贝叶斯分析

获取原文
获取原文并翻译 | 示例

摘要

Identifying genes underlying cancer development is critical to cancer biology and has important implications across prevention, diagnosis and treatment. Cancer sequencing studies aim at discovering genes with high frequencies of somatic mutations in specific types of cancer, as these genes are potential driving factors (drivers) for cancer development. We introduce a hierarchical Bayesian methodology to estimate gene-specific mutation rates and driver probabilities from somatic mutation data and to shed light on the overall proportion of drivers among sequenced genes. Our methodology applies to different experimental designs used in practice, including one-stage, two-stage and candidate gene designs. Also, sample sizes are typically small relative to the rarity of individual mutations. Via a shrinkage method borrowing strength from the whole genome in assessing individual genes, we reinforce inference and address the selection effects induced by multistage designs. Our simulation studies show that the posterior driver probabilities provide a nearly unbiased false discovery rate estimate. We apply our methods to pancreatic and breast cancer data, contrast our results to previous estimates and provide estimated proportions of drivers for these two types of cancer.
机译:鉴定潜在的癌症发展基因对于癌症生物学至关重要,并且在预防,诊断和治疗方面具有重要意义。癌症测序研究旨在发现特定类型癌症中具有高频率体细胞突变的基因,因为这些基因是癌症发展的潜在驱动因素(驱动器)。我们引入了分级贝叶斯方法,以从体细胞突变数据估计基因特异性突变率和驱动器概率,并阐明测序基因中驱动器的总体比例。我们的方法适用于实践中使用的不同实验设计,包括一阶段,两阶段和候选基因设计。而且,相对于单个突变的稀有性而言,样本量通常较小。通过收缩方法从整个基因组中借用力量来评估单个基因,我们加强了推论并解决了多阶段设计引起的选择效应。我们的仿真研究表明,后验驾驶员概率提供了几乎无偏的错误发现率估计。我们将我们的方法应用于胰腺癌和乳腺癌数据,将我们的结果与先前的估计值进行对比,并提供了这两种类型癌症的驱动因素的估计比例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号